Intra- and postoperative catumaxomab in patients with epithelial ovarian cancer: safety and two-year efficacy results from a multicentre, single-arm, phase II study

por Sehouli, J, Reinthaller, A, Marth, C, Reimer, D, Reimer, T, Stummvoll, W, Angleitner-Boubenizek, L, Brandt, B, Chekerov, R
Publicado 2014

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

por Windbichler, G H, Hausmaninger, H, Stummvoll, W, Graf, A H, Kainz, C, Lahodny, J, Denison, U, Müller-Holzner, E, Marth, C
Publicado 2000